The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
Innovative solutions and a deep understanding of the market makes this a unique combination
Subscribe To Our Newsletter & Stay Updated
